The Evolution of GLP-1 Medications in Germany: A Comprehensive Guide to Treatment, Regulation, and AccessOver the last few years, the landscape of metabolic health and obesity management has undergone a paradigm shift, mainly driven by the development of GLP-1 (Glucagon-like peptide-1) receptor agonists. In Germany, a nation understood for its